Precision Life Sciences LLC
Precision Life Sciences LLC was paid $855K by Medicaid between Dec 2021 and Dec 2024, across 58 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 42% of everything it billed.
OLIVE BRANCH, MS 38654
Next to other Clinical Medical Laboratory providers in Mississippi
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 77 | $1K | |
| 2022 | 21,392 | $513K | |
| 2023 | 21,541 | $223K | |
| 2024incomplete | 11,172 | $117K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 42% | 9,810 | 2,199 | $358K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 19% | 12,522 | 2,814 | $166K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 19% | 3,239 | 837 | $158K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 7.3% | 1,984 | 1,377 | $63K |
| 87481 | 2.1% | 1,663 | 1,082 | $18K | |
| 87631 | 1.8% | 240 | 235 | $15K | |
| 87150 | 1.3% | 829 | 424 | $11K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 393 | 290 | $9K |
| 87500 | <1% | 1,689 | 1,098 | $6K | |
| 87641 | <1% | 1,611 | 1,052 | $5K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,251 | 715 | $5K |
| 87653 | <1% | 1,131 | 849 | $5K |
46 more codes
| 87541 | <1% | 240 | $4K | |
| 87581 | <1% | 240 | $4K | |
| 87486 | <1% | 240 | $4K | |
| 87640 | <1% | 254 | $4K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,632 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,862 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 666 | $3K |
| 80061 | Lipid panel | <1% | 1,283 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,470 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 899 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 679 | $1K |
| 80164 | <1% | 270 | $683.33 | |
| 82607 | <1% | 290 | $623.21 | |
| 85027 | <1% | 462 | $560.49 | |
| 87471 | <1% | 206 | $557.89 | |
| 80177 | <1% | 254 | $485.22 | |
| 84439 | <1% | 406 | $387.95 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 634 | $387.89 |
| 81226 | <1% | 20 | $360.73 | |
| 82747 | <1% | 58 | $277.63 | |
| 81225 | <1% | 20 | $233.09 | |
| 83735 | <1% | 165 | $171.17 | |
| 84481 | <1% | 151 | $159.93 | |
| 81230 | <1% | 20 | $139.85 | |
| 81231 | <1% | 20 | $139.85 | |
| 81227 | <1% | 20 | $139.85 | |
| 81328 | <1% | 20 | $139.85 | |
| 81401 | <1% | 20 | $109.60 | |
| 83880 | <1% | 94 | $86.58 | |
| 82728 | <1% | 16 | $71.56 | |
| 81355 | <1% | 20 | $70.56 | |
| 83550 | <1% | 89 | $66.34 | |
| 81241 | <1% | 20 | $58.70 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 1,266 | $58.40 |
| 83540 | <1% | 99 | $57.99 | |
| 80050 | General health panel | <1% | 16 | $56.27 |
| 81240 | <1% | 20 | $52.55 | |
| 81291 | <1% | 20 | $52.27 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 1,268 | $36.03 |
| 84460 | <1% | 65 | $23.96 | |
| 84450 | <1% | 60 | $13.71 | |
| 81005 | <1% | 60 | $11.49 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 18 | $3.79 |
| 36415 | Collection of venous blood by venipuncture | <1% | 69 | $3.63 |
| 84480 | 0% | 14 | $0.00 | |
| 81418 | 0% | 105 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.